论文部分内容阅读
近年国内已有应用“人胎肝细胞悬液”(FLC)治疗重症肝炎及慢性活动性肝炎获得较好疗效的报道。但临床广泛应用FLC尚存在两个亟待解决的问题:(1)人胎肝细胞来源困难;(2)胎肝细胞活性难以较长时间保存。我们从Labrecque氏研究肝
In recent years, there have been reports of using the “human fetal liver cell suspension” (FLC) treatment of severe hepatitis and chronic active hepatitis get better curative effect. However, there are still two urgent problems to be solved in clinical application of FLC: (1) Difficulty in source of human fetal hepatocytes; (2) Fetal hepatocyte activity is difficult to preserve for a long time. We studied the liver from Labrecque